Topic: Medicaid
This time, Novartis (NVS) will pay $422.5 million for illegally promoting its Trileptal epilepsy med for unapproved uses, such as bipolar disorder and neuropathic pain, along with five other drugs - Diovan, Zelnorm, Sandostatin, Exforge and Tekturna. One of the lawsuits was ...
Genzyme today rejected the $18.5 billion takeover offer presented by French drug maker Sanofi-Aventis in a so-called " Genzyme, which has recently faced manufacturing problems, says it's not "the right time" to sell, calling Sanofi's offer an "opportunistic proposal with an unreasonable ...
A federal judge in Massachusetts has granted Attorney General Drew Edmondson's request to intervene in a lawsuit against drug manufacturer Wyeth.. Wyeth, a unit of Pfizer Inc., is accused of overcharging state Medicaid programs for the stomach acid medications Protonix Oral and ...
Three drugmakers post improved 1st-quarter profits and sales, rest of year looks less rosyThree top drugmakers on Thursday posted healthy increases in first-quarter sales and profits, with strong sales of key drugs buoying Bristol-Myers Squibb Co., AstraZeneca LP and Sanofi-Aventis SA.Their positive ...
The drugmaker Merck & Co. said Friday the federal health care overhaul will reduce its revenue by about $170 million this year and by roughly double that amount next year — less than the impact some rivals have reported. Its shares rose ...
GOOD NEWS, BAD NEWS: Amgen Inc.'s first-quarter profit beat Wall Street expectations as sales of its anti-infection drugs improved. However the company said 2010 results will come in at the low end of its forecast due to health reform costs.DISCOUNTS: Amgen said ...
Drug Companies Agree To $7.75 Million settlement with state [Milwaukee Journal Sentinel]. From Milwaukee Journal Sentinel (WI) (April 20, 2010). Apr. 20--Wisconsin received $7.75 million from four pharmaceutical companies accused of defrauding the state Medicaid program under a settlement announced by Attorney ...
German drugmaker, state of Wisconsin reach $7.75M settlement on suit alleging Medicaid fraudA German-based pharmaceutical company has agreed to pay $7.75 million to settle allegations that four of its subsidiaries committed price fraud, Wisconsin Attorney General J.B. Van Hollen said Tuesday.The four ...
THE INFLUENCE GAME: Lobbying pays off as drug industry hits jackpot with health overhaul.Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama's health care law even as it ...
NJ drug company agrees to pay $3.5 settlement with federal authorities Federal prosecutors say a New Jersey pharmaceutical company has agreed to pay $3.5 million to settle allegations that it claimed its heart drug was eligible for Medicaid reimbursement.The U.S. attorney's office ...